FDA Import Refusal 1FX-8809105-3/10002/1 — IND SWIFT LIMITED
The FDA refused shipment 1FX-8809105-3/10002/1 from IND SWIFT LIMITED (India) on Oct 5, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 9999978,9999978,9999979,9999979 This firm has 1 other import refusal on record.
Refusal Details
- Date
- Oct 5, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 9999978,9999978,9999979,9999979